Medicare Enrolled
Dr. Stephen Gillard, MD
Optician · Plymouth, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gillard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gillard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gillard
Dr. Stephen Gillard is an optician specialist in Plymouth, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gillard performed 17,431 Medicare services across 9,179 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gillard received a total of $6,974 from 58 pharmaceutical and/or device companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gillard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in MA
$6,974 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,431
Medicare services
Top 4% in MA for optician
9,179
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~917 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,276 | $2 | $10 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
1,759 | $49 | $258 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,328 | $68 | $245 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,324 | $9 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,312 | $98 | $350 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
1,219 | $5 | $262 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,072 | $8 | $25 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
876 | $8 | $25 |
| PSA test (prostate cancer screening) | 788 | $18 | $100 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
598 | $34 | $85 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
463 | $2 | $20 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
413 | $194 | $725 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
278 | $49 | $85 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 231 | $134 | $750 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
190 | $34 | $90 |
| Simple change of bladder tube | 185 | $78 | $300 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
146 | $22 | $142 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
129 | $18 | $100 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
122 | $66 | $307 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
116 | $24 | $89 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
115 | $46 | $201 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
113 | $49 | $300 |
| Bladder cancer protein test A laboratory test that measures specific proteins to help diagnose and monitor bladder cancer. |
105 | $21 | $46 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
101 | $118 | $477 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
92 | $11 | $90 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
82 | $39 | $85 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
73 | $469 | $3,000 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
70 | $8 | $25 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
70 | $83 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
69 | $101 | $375 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
67 | $71 | $450 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
66 | $20 | $50 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
46 | $34 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
46 | $34 | $85 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
42 | $69 | $175 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
40 | $329 | $1,962 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
38 | $34 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $42 | $150 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $126 | $2,296 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
24 | $263 | $1,000 |
| Liver function blood test panel | 24 | $7 | $25 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
23 | $2 | $10 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
22 | $63 | $289 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
22 | $2,506 | $9,000 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $200 | $800 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
20 | $567 | $3,500 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
20 | $40 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $142 | $389 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $182 | $648 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $17 | $411 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
19 | $104 | $442 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
15 | $639 | $1,800 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
14 | $92 | $350 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
13 | $49 | $1,390 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
13 | $121 | $3,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
20.7% medium
78.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,974
Total received (2018-2024)
Avg $996/year across 7 years
Top 15% in MA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
301
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,681 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$293 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,567
2023
$1,403
2022
$957
2021
$832
2020
$500
2019
$752
2018
$962
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
IMMUNITYBIO, INC.
$187
DENTSPLY IH AB
$175
Ferring Pharmaceuticals Inc.
$169
ConvaTec Inc.
$135
Laborie Medical Technologies Corp.
$114
Endo USA, Inc.
$104
Janssen Biotech, Inc.
$79
Endo Pharmaceuticals Inc.
$73
Myriad Genetic Laboratories, Inc.
$62
180 Medical, Inc.
$55
Antares Pharma, Inc.
$53
ABBVIE INC.
$44
C. R. Bard, Inc. & Subsidiaries
$41
Telix Pharmaceuticals
$39
UROGEN PHARMA, INC.
$38
PFIZER INC.
$35
Dendreon Pharmaceuticals LLC
$30
AstraZeneca Pharmaceuticals LP
$28
BIOPROTECT MEDICAL, INC.
$27
ACCORD HEALTHCARE, INC.
$25
PROGENICS PHARMACEUTICALS, INC.
$23
Calyxo, Inc.
$16
Astellas Pharma US Inc
$15
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,058
Janssen Biotech, Inc.
$584
Dendreon Pharmaceuticals LLC
$388
DENTSPLY IH AB
$372
Boston Scientific Corporation
$346
ConvaTec Inc.
$280
PFIZER INC.
$253
Progenics Pharmaceuticals, Inc.
$252
PROCEPT BioRobotics Corporation
$226
Endo Pharmaceuticals Inc.
$218
IMMUNITYBIO, INC.
$187
180 Medical, Inc.
$185
Ferring Pharmaceuticals Inc.
$169
Augmenix, Inc.
$156
AbbVie, Inc.
$150
Antares Pharma, Inc.
$149
Laborie Medical Technologies Corp.
$133
ABBVIE INC.
$120
Myriad Genetic Laboratories, Inc.
$120
Rochester Medical Corporation
$110
Endo USA, Inc.
$104
UROVANT SCIENCES INC
$101
DENTSPLY IH Inc.
$92
C. R. Bard, Inc. & Subsidiaries
$84
Supernus Pharmaceuticals, Inc.
$78
GENZYME CORPORATION
$61
Telix Pharmaceuticals
$58
NeoTract Inc.
$58
UROGEN PHARMA, INC.
$55
AstraZeneca Pharmaceuticals LP
$53
Amgen Inc.
$51
Medtronic USA, Inc.
$49
Travere Therapeutics, Inc.
$47
Palette Life Sciences, Inc.
$43
Sumitomo Pharma America, Inc.
$42
Acerus Pharmaceuticals Corporation
$41
Blue Earth Diagnostics Limited
$40
Innovation Technologies Inc
$35
Aytu BioScience, Inc
$31
Agiliti Surgical, Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$29
BIOPROTECT MEDICAL, INC.
$27
Axonics, Inc.
$25
ACCORD HEALTHCARE, INC.
$25
Novartis Pharmaceuticals Corporation
$24
PROGENICS PHARMACEUTICALS, INC.
$23
AbbVie Inc.
$23
Sun Pharmaceutical Industries Inc.
$23
UroGen Pharma, Inc.
$22
Mission Pharmacal Company
$22
NxThera, Inc.
$20
ROCHESTER MEDICAL CORPORATION
$17
Calyxo, Inc.
$16
HealthTronics Mobile Solutions, LLC
$15
C. R. BARD, INC. & SUBSIDIARIES
$15
Allergan Inc.
$14
Hollister Incorporated
$13
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 29.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axonics · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CURE CATHETER · CURE TWIST · CVAC ASPIRATION SYSTEM · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · GentleCath · ILLUCCIX · INTERSTIM · Irrisept · JELMYTO · JEVTANA · LOFRIC · LYNPARZA · Livalo · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Mobile Laser Services · Myrbetriq · NOCDURNA · Natesto · ONLI · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · Rezum · SOLYX · SPEEDICATH · Sonablate · SpaceOAR · SpeediCath · TLANDO · TOVIAZ · Thiola · URIBEL · Upsylon · UroLift · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
119
Per 100K population
22.4
County median income
$109,698
Nearest hospital
BETH ISRAEL DEACONESS HOSPITAL PLYMOUTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gillard is a clinical cardiology specialist, with above-average Medicare volume (top 4% in MA), with low-engagement industry engagement in the top 15% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gillard experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Gillard performed 3,276 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gillard receive payments from pharmaceutical companies?
Yes. Dr. Gillard received a total of $6,974 from 58 companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gillard's costs compare to other opticians in Plymouth?
Dr. Gillard's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gillard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Plymouth
Browse opticians in Plymouth ranked by procedure volume and transparency data.
Highest volume
Top Opticians in MA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in MA
Which MA opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology